Public Health Foundation Enterprises, Inc.
17
2
3
10
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 25/100
5.9%
1 terminated/withdrawn out of 17 trials
90.9%
+4.4% vs industry average
18%
3 trials in Phase 3/4
50%
5 of 10 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (17)
HIV Prevention and Care Engagement in Nepal
Role: lead
MyPrEP Plus: Development and Pilot Testing of Novel Preexposure Prophylaxis Decision Support Tools for Transgender Women
Role: lead
DOT Diary Mobile App for Pre-Exposure Prophylaxis Adherence in Young Men
Role: lead
PrEPsmart 2-1-1 Pilot
Role: lead
The Cheeky Study: A Novel Delivery System for CAB-RPV LA
Role: lead
Comparing Mobile Health Strategies to Improve Pre-exposure Prophylaxis Use (PrEP) for HIV Prevention
Role: lead
A Study Evaluating An Integrated Pharmacy Digital Diary and Delivery Strategy to Increase PrEP Use Among MSM and TGW
Role: lead
Comparison of Men's Prevention Apps to Research Efficacy
Role: lead
mHealth Systems Navigation- Breaking Systems Barriers for Trans Women Living With HIV
Role: lead
DOT Diary Optimization Pilot: A Pilot Study to Optimize the DOT Diary App to Measure PrEP Adherence
Role: lead
LYNX: A Novel Mobile App to Support Linkage to HIV/STI Testing PrEP for Young Men Who Have Sex With Men
Role: lead
The Stay Study: A Demonstration Project Advancing PrEP Delivery in the San Francisco Bay Area Transgender Community
Role: lead
HOME Study: a Combination Support Package to Increase Uptake of PrEP and HIV/STI Testing
Role: lead
Personalized HIV and STI Testing Tool
Role: lead
Examining Hair to Determine Tenofovir Exposure
Role: lead
Mirtazapine to Reduce Methamphetamine Use Among MSM With High-risk HIV Behaviors
Role: collaborator
Acceptability of Pharmacologic Treatment for Methamphetamine Dependence Among MSM
Role: collaborator
All 17 trials loaded